Acute Myeloid Leukemia With T(3;21)(q26.2;q22) Developing Following Low‑dose Methotrexate Therapy for Rheumatoid Arthritis and Expressing Two AML1/MDS1/EVI1 Fusion Proteins: A Case Report

Oncology Letters- Greece

doi 10.3892/ol.2017.6151

Full Text

Abstract

Available in

Date

Authors

Publisher

Spandidos Publications

Related search

Acute Myeloid Leukemia With Inv3(q21;q26.2) or T(3;3)(q21;q26.2)

2020English

T(3;21)(p12;q22)

Atlas of Genetics and Cytogenetics in Oncology and Haematology
Cancer ResearchOncologyGeneticsHematology
2011English

T(3;21)(q26;q22)

Atlas of Genetics and Cytogenetics in Oncology and Haematology
Cancer ResearchOncologyGeneticsHematology
2010English

AML1 (Acute Myeloid Leukemia 1)

Atlas of Genetics and Cytogenetics in Oncology and Haematology
Cancer ResearchOncologyGeneticsHematology
2010English

Adult T-Cell Leukemia/Lymphoma as a Methotrexate-Associated Lymphoproliferative Disorder in a Patient With Rheumatoid Arthritis - A Case Report

Internal Medicine
Internal MedicineMedicine
2018English

Targeted Degradation of the AML1/MDS1/EVI1 Oncoprotein by Arsenic Trioxide

Cancer Research
Cancer ResearchOncology
2006English

Safety of Low Dose Methotrexate in Elderly Patients With Rheumatoid Arthritis

Postgraduate Medical Journal
Medicine
2000English

Myeloid Leukemia With T(7;21)(p22;q22) and 5q Deletion

Oncology Reports
MedicineCancer ResearchOncology
2013English

Cytomegalovirus Pneumonia in a Patient With Rheumatoid Arthritis Treated With Low Dose Methotrexate and Prednisone.

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
1991English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy